Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challengeChristine M. Parseghian, Scott Kopetz, Jason T. Henry et al.|Annals of Oncology|2018Cited by 239
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping PanelJason Willis, Justin I. Odegaard, Martina I. Lefterova et al.|Clinical Cancer Research|2019Cited by 237
Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung AdenocarcinomaMaria Schwaederlé, Razelle Kurzrock, Sandip Pravin Patel et al.|Clinical Cancer Research|2017Cited by 147
Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patientsS.T. Kim, Kimberly C. Banks, Eirini Pectasides et al.|Annals of Oncology|2018Cited by 105
Genomic profile of advanced breast cancer in circulating tumour DNABelinda Kingston, Nicholas C. Turner, Rosalind Cutts et al.|Nature Communications|2021Cited by 95